3.22.2.2 html 70 98 1 false 15 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://lsmg/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS (Unaudited) Sheet http://lsmg/role/BalanceSheets BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://lsmg/role/BalanceSheetsParenthetical BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS (Unaudited) Sheet http://lsmg/role/StatementsOfOperations STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://lsmg/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (EQUITY) (Unaudited) Sheet http://lsmg/role/StatementsOfChangesInStockholdersDeficiencyEquity STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (EQUITY) (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperations BASIS OF PRESENTATION AND NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://lsmg/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - PHARMACEUTICAL DEVELOPMENT PROJECT Sheet http://lsmg/role/PharmaceuticalDevelopmentProject PHARMACEUTICAL DEVELOPMENT PROJECT Notes 9 false false R10.htm 00000010 - Disclosure - CAPITAL STOCK Sheet http://lsmg/role/CapitalStock CAPITAL STOCK Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTY TRANSACTIONS AND AMOUNTS DUE Sheet http://lsmg/role/RelatedPartyTransactionsAndAmountsDue RELATED PARTY TRANSACTIONS AND AMOUNTS DUE Notes 11 false false R12.htm 00000012 - Disclosure - FINANCIAL INSTRUMENTS Sheet http://lsmg/role/FinancialInstruments FINANCIAL INSTRUMENTS Notes 12 false false R13.htm 00000013 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Policies) Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperationsPolicies BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Policies) Policies 13 false false R14.htm 00000014 - Disclosure - CAPITAL STOCK (Tables) Sheet http://lsmg/role/CapitalStockTables CAPITAL STOCK (Tables) Tables http://lsmg/role/CapitalStock 14 false false R15.htm 00000015 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Details Narrative) Sheet http://lsmg/role/BasisOfPresentationAndNatureOfOperationsDetailsNarrative BASIS OF PRESENTATION AND NATURE OF OPERATIONS (Details Narrative) Details http://lsmg/role/BasisOfPresentationAndNatureOfOperationsPolicies 15 false false R16.htm 00000016 - Disclosure - PHARMACEUTICAL DEVELOPMENT PROJECT (Details Narrative) Sheet http://lsmg/role/PharmaceuticalDevelopmentProjectDetailsNarrative PHARMACEUTICAL DEVELOPMENT PROJECT (Details Narrative) Details http://lsmg/role/PharmaceuticalDevelopmentProject 16 false false R17.htm 00000017 - Disclosure - CAPITAL STOCK (Details) Sheet http://lsmg/role/CapitalStockDetails CAPITAL STOCK (Details) Details http://lsmg/role/CapitalStockTables 17 false false R18.htm 00000018 - Disclosure - CAPITAL STOCK (Details Narrative) Sheet http://lsmg/role/CapitalStockDetailsNarrative CAPITAL STOCK (Details Narrative) Details http://lsmg/role/CapitalStockTables 18 false false R19.htm 00000019 - Disclosure - RELATED PARTY TRANSACTIONS AND AMOUNTS DUE (Details Narrative) Sheet http://lsmg/role/RelatedPartyTransactionsAndAmountsDueDetailsNarrative RELATED PARTY TRANSACTIONS AND AMOUNTS DUE (Details Narrative) Details http://lsmg/role/RelatedPartyTransactionsAndAmountsDue 19 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 7 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DueToRelatedPartiesCurrent, us-gaap:PreferredStockSharesIssued, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 - lsmg-10q.htm 30, 31, 78, 79, 82, 83, 84 [EFM.6.05.45.cover-page-fact-not-visible] Submission type 10-Q has 1 cover page fact(s) in ix:hidden that should be visible or referenced by an -sec-ix-hidden style property: EntityInteractiveDataCurrent - lsmg-10q.htm 29 - lsmg-10q.htm 29 [dqc-0015-Negative-Values] Fact us-gaap:GeneralAndAdministrativeExpense has a value of -5665 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:GeneralAndAdministrativeExpense fact are: Context: From2022-04-012022-06-30, Unit: USD, Rule Element Id: 2713. lsmg-10q.htm 1418 [dqc-0015-Negative-Values] Fact us-gaap:GeneralAndAdministrativeExpense has a value of -3929 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:GeneralAndAdministrativeExpense fact are: Context: From2022-01-01to2022-06-30, Unit: USD, Rule Element Id: 2713. lsmg-10q.htm 1420 lsmg-10q.htm lsmg-20220630.xsd lsmg-20220630_cal.xml lsmg-20220630_def.xml lsmg-20220630_lab.xml lsmg-20220630_pre.xml lsmg-ex31_1.htm lsmg-ex32_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true